Latest headlines
Amgen News
The latest Amgen (AMGN) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these AMGN headlines next to the live Amgen Fear and Greed Index.
Latest Amgen Headlines60
European Regulator Calls for Amgen's Tavneos to Have Authorization Revoked
wsj.com · Jun 26, 2026
EMA recommends revoking marketing authorisation for Amgen's rare-disease drug
reuters.com · Jun 26, 2026
Amgen (AMGN) Increases Despite Market Slip: Here's What You Need to Know
zacks.com · Jun 24, 2026
Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
fool.com · Jun 23, 2026
Are Biosimilars Becoming a Key Pillar of Amgen's Growth Story?
zacks.com · Jun 23, 2026
2 Underrated Weight Loss Stocks to Buy and Hold
fool.com · Jun 23, 2026
Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026?
fool.com · Jun 19, 2026
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
zacks.com · Jun 19, 2026
Amgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know
zacks.com · Jun 17, 2026
The Healthcare M&A Wave
forbes.com · Jun 17, 2026
Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term
zacks.com · Jun 17, 2026
AMGN DCF Analysis: Intrinsic Value $292 vs Price $355
gurufocus.com · Jun 15, 2026
Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape
prnewswire.com · Jun 14, 2026
Drugmakers race to find a place in the next wave of obesity drugs
cnbc.com · Jun 13, 2026
Amgen taps research firm to reassess Tavneos data
reuters.com · Jun 11, 2026
Healthcare ETFs: From Broad Exposure to Big Breakthroughs
etftrends.com · Jun 11, 2026
Amgen (AMGN) Registers a Bigger Fall Than the Market: Important Facts to Note
zacks.com · Jun 10, 2026
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
zacks.com · Jun 10, 2026
Can Amgen's MariTide Win Share in the Fast-Growing Obesity Market?
zacks.com · Jun 10, 2026
Amgen Inc. (AMGN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
seekingalpha.com · Jun 9, 2026
Amgen Eyes 2026 ‘Springboard' as Growth Drugs Offset Patent Pressure
marketbeat.com · Jun 9, 2026
Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying
forbes.com · Jun 9, 2026
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
zacks.com · Jun 8, 2026
AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
gurufocus.com · Jun 7, 2026
AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
prnewswire.com · Jun 7, 2026
The Smartest Dividend ETF to Buy With $1,000 Right Now -- and It's Up 19% in 2026
fool.com · Jun 6, 2026
Amgen: A Biotech Giant's Path to Recovery and Growth
fool.com · Jun 5, 2026
Amgen: Time For An Upgrade? Yes, I Think So
seekingalpha.com · Jun 5, 2026
Amgen Touts MariTide, AI Gains and 2026 Growth Plans at Jefferies Conference
marketbeat.com · Jun 5, 2026
AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
prnewswire.com · Jun 4, 2026
Amgen Inc. (AMGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript
seekingalpha.com · Jun 4, 2026
Biotech ETFs: Which ETF Offers Lower Fees? IBBQ or XPH?
fool.com · Jun 4, 2026
ЕВРОПЕЙСКАЯ КОМИССИЯ ОДОБРИЛА ПРЕПАРАТ AMGEN IMDYLLTRA® ДЛЯ ЛЕЧЕНИЯ МЕЛКОКЛЕТОЧНОГО РАКА ЛЕГКОГО НА ЗАПУЩЕННОЙ СТАДИИ
prnewswire.com · Jun 3, 2026
AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026
prnewswire.com · Jun 3, 2026
Amgen Secures EU Nod for Imdylltra in Lung Cancer Indication
zacks.com · Jun 2, 2026
Here's Why Amgen (AMGN) is a Strong Momentum Stock
zacks.com · Jun 1, 2026
AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE
prnewswire.com · May 29, 2026
This Boring Income Portfolio Strategy Could Unlock 300%+ Upside
forbes.com · May 27, 2026
Novo Nordisk vs. Amgen: Which Pharma Stock Is the Better Buy?
zacks.com · May 27, 2026
Ember LifeSciences announces new strategic investments boosting Series A to $27M
prnewswire.com · May 27, 2026
130 Years of the Dow: Why It Still Matters for Advisors
etftrends.com · May 26, 2026
AMGN Stock Down 13% in 3 Months: Buy the Dip or Book Profits?
zacks.com · May 26, 2026
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
zacks.com · May 26, 2026
Amgen's Growth Engine Is Just Getting Started
seekingalpha.com · May 26, 2026
AMGN Fairly Valued by DCF at $292
gurufocus.com · May 26, 2026
Doctors in Japan can again prescribe an Amgen rare-disease drug to new patients, reversing a recommendation made only days ago following 20 deaths
wsj.com · May 21, 2026
Amgen says CFO Peter Griffith to retire, names Dittrich as successor
reuters.com · May 19, 2026
AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH
prnewswire.com · May 19, 2026
Amgen's rare disease drug linked to deaths, liver injuries in Japan, WSJ reports
reuters.com · May 15, 2026
Twenty people in Japan who took an Amgen rare immune-disease drug have died, according to the company that sells the medicine in Japan. U.S. drug regulators had asked Amgen to voluntarily withdraw the drug.
wsj.com · May 15, 2026
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
zacks.com · May 15, 2026
Amgen Inc. (AMGN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
seekingalpha.com · May 13, 2026
New Study Finds These Sectors Produce the Most 100-Bagger Stocks
247wallst.com · May 12, 2026
AMGN Fairly Valued by DCF at $292
gurufocus.com · May 11, 2026
2 Dividend Stocks to Double Up On Right Now
fool.com · May 8, 2026
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
prnewswire.com · May 7, 2026
RPRX vs. AMGN: Which Stock Is the Better Value Option?
zacks.com · May 6, 2026
Guggenheim Trims Amgen Price Target to $340: Is the Biotech Giant Losing Its Edge?
247wallst.com · May 4, 2026
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
zacks.com · May 4, 2026
Amgen to invest additional $300 million to boost US manufacturing footprint
reuters.com · May 4, 2026
Why Is Amgen Up or Down Today?
When Amgen (AMGN) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a AMGN move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Amgen is up or down today.
How Amgen News Affects the Price
News does not move the Amgen (AMGN) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Amgen Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Amgen trading volume. That is the chain to watch: headline, sentiment, volume, then the AMGN price.
Trade the Amgen News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Amgen trading volume spike on a big story, check the Amgen price history for context, follow the live AMGN price, see the Amgen price prediction, and read the Amgen Fear and Greed Index for mood.
How do you feel about Amgen?
1DFrequently asked questions
Why is Amgen up or down today?
What is the latest Amgen news?
Where does Amgen news come from?
How often is Amgen news updated?
How does Amgen news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and more than 100 individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.